Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 12, Number 2—February 2006

Global Socioeconomic Impact of Cystic Echinococcosis

Christine M. Budke*, Peter Deplazes*, and Paul R. Torgerson*Comments to Author 
Author affiliations: *University of Zürich, Zürich, Switzerland

Main Article

Table 5

Global annual cystic echinococcosis–associated economic losses to humans

Region Total adjusted economic losses (95% CI)*(US $) Total adjusted economic losses (95% CI)† (US $)
Western Europe, USA, Canada, Australia, New Zealand $309,983,585 ($244,256,327–$383,371,741) $354,460,281 ($277,178,852–$440,438,597)
Middle Eastern Crescent $197,276,106 ($158,870,204–$240,282,181) $564,496,304 ($454,402,304–$690,682,060)
Formerly socialist economies of Europe and Russia $46,896,902 ($37,750,210–$57,355,873) $143,921,865 ($114,323,294–$176,555,114)
China $146,129,578 ($114,279,187–$181,937,463) $663,712,150 ($516,048,103–$826,353,341)
Other Asia and Islands $1,535,990 ($1,159,946–$1,946,632) $2,412,386 ($1,826,342–$3,074,240)
Sub-Saharan Africa $832,295 ($649,915–$1,035,681) $5,176,229 ($3,710,869–$6,969,680)
Latin America and the Caribbean $48,396,449 ($38,408,001–$59,672,173) $120,717,047 ($95,789,339–$148,939,896)
India $12,930,073 ($9,674,489–$16,499,072) $63,422,693 ($47,576,673–$80,430,630)
World $763,980,979 ($676,048,731–$857,982,275) $1,918,318,955 ($1,700,574,632–$2,142,268,992)

*Income losses based on per capita gross national income (GNI) (Atlas method); CI, confidence interval.
†Income losses based on purchasing power parity–adjusted per capita GNI.

Main Article

Page created: February 02, 2012
Page updated: February 02, 2012
Page reviewed: February 02, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.